媒体，血清和生物技术试剂的全球市场
报告亮点
The global market for media, sera and reagents used in cell culture will grow from nearly $3.6 billion in 2016 to $4.6 billion by 2021 at a compound annual growth rate (CAGR) of 5.5% between 2016 and 2021.
报告包括
- An overview of the global markets and technologies for media, sera and reagents used in biotechnology.
- 全球市场趋势的分析，以及2015年和2016年的数据，以及2021年复合年增长率（复合年增长率）的预测。
- Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media.
- 细胞培养工业结构的详细分析。
- 讨论涵盖细胞培养技术的应用，重点是在研究，生产和合同细分市场中使用。
- Profiles of major players in the media, sera, and reagents industry.
Report Scope
通过药物开发过程从药物发现点使用细胞培养产物。细胞培养产品主要用于研究目的，生产生物制药和教育目的。该报告着重于细胞文化行业中使用的媒体，血清和试剂产品的全球市场，并讨论了生物医学和生命科学研究各个领域的应用。该报告涉及整个细胞文化市场，包括研究细分市场，生产部门，合同细分市场和“其他”细分市场，其中包括体外诊断和教育部门。
该研究的范围在全球范围内。报告中讨论了当前的市场动态，市场驱动因素，限制因素，趋势，监管问题和战略发展。在区域分析中，该报告确定和分析了美国，欧洲和新兴市场的市场规模和预测。生物技术的媒体，血清和试剂新兴市场包括印度，中国，日本，韩国，台湾，加拿大，非洲，澳大利亚，新西兰和其他国家。
Also included in the report are relevant patent analyses and comprehensive profiles of companies that lead the market for media, sera and reagents in the cell culture industry. A few prominent players in this industry are Thermo Fisher Scientific, Merck KGaA, GE Healthcare Life Sciences, BD Biosciences, and Corning Inc.
Analyst Credentials
Shalini Shahani Dewanfocuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
报告亮点
The global market for cell culture products will grow from nearly $3.2 billion in 2014 to nearly $4.1 billion by 2019 at a compound annual growth rate (CAGR) of 5.1% between 2014 and 2019.
报告包括
- An overview of the global markets and technologies for media, sera and reagents used in biotechnology.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- 还涵盖了有关各种细胞培养技术的不同类型的细胞培养物和产品的信息，以及使用各种培养基的优势和缺点。
- 细胞培养工业结构的详细分析。
- Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production and contract segments.
- Comprehensive profiles of major players in the media, sera, and reagents industry.
报告亮点
The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.
报告亮点
- Total worldwide sales revenues for media, sera, and reagent used in the biotechnology were $2,546.2 million in 2010, and are expected to increase to more than $3800 Million in 2015, at a compound annual growth rate (CAGR) of 8.7%.
- 2010年最大的生物技术细分是试剂。生物技术的所有试剂从2010年的1,0.666亿美元增加到2015年的近1,85040万美元，复合年增长率（CAGR）为11.6％。
- Sales of Media will experience high growth. This market segment was worth $821.8 million in 2010 and will increase at a 8.6% compound annual growth rate (CAGR) to reach a value of $1,242.4 million in 2015.
- Sales of Sera will experience moderate growth. This market segment was worth $31657.8 million in 2010 and will increase at a 3.3% compound annual growth rate (CAGR) to reach a value of $772.5 million in 2015.
报告亮点
-
The total U.S. sales of media, sera, and reagents for biotechnology was $979 million in 2005 and almost $1.1 billion in 2006. At a compound annual growth rate (CAGR) of 8.9%, this market will grow to reach more than $1.6 billion in 2011.
-
血清在市场上的增长速度会慢得多。该特定行业在2006年价值3.385亿美元，到2011年将达到4.01亿美元，复合年增长率仅为3.5％。
-
Reagents have the greatest potential for growth, worth $382 million in 2006 and growing at a CAGR of 12.8% to reach almost $700 million by 2011.
报告亮点
-
The market for media, sera and reagents in U.S. is estimated at $915.6 million in 2003. The market is expected to rise at an AAGR (average annual growth rate) of 13.1% and reach $1.7 billion by 2008.
-
U.S. sales for media are expected to reach $282.3 million in 2003 and $452.5 million in 2008, an AAGR of 9.9%.
-
血清市场虽然很慢，却以3.5％的AAGR增长，2008年将从2003年的2.96亿美元达到3.521亿美元。
-
The reagent market in 2003 is estimated at $337.3 million and is expected to rise at an AAGR of 21.5% and reach $892.6 million by 2008.
-
由于细胞培养的支出增加，试剂段是生长最快的生长。每年都有十到12个新的生物响应修饰符上市。
报告亮点
-
The U.S. cell culture media market has been growing at a surprisingly fast pace since the last edition of this report, and some of the media suppliers are enjoying a growth rate higher than the overall rate. The U.S. market for cell culture media was estimated to be about $169.5 million in 1999. This is projected to grow to $190.2 million in 2000, and to reach $343.7 million in the year 2005. The estimated average annual growth rate is projected to be about 12.5%.
-
The sera portion of the U.S. market was an estimated $173.9 million in 1999. It should grow to $183.2 million by 2000, and $238.4 million by 2005. The average growth rate is expected to be 5.4% per year throughout this period.
-
在1999年，在细胞培养物中使用的试剂市场估计为1.517亿美元。到2000年，该市场应增长到1.704亿美元，到2005年为3.151亿美元。预计该期间的平均增长率预计为每年13.0％。